ADMA Biologics, Inc.

ADMA

$9.58

+0.74%

N/A+$0.07

Healthcare

Biotechnology

NASDAQ

Active Trading

ADMA Biologics, Inc. functions as a biopharmaceutical company specializing in the development, manufacturing, and commercialization of advanced biologic therapies derived from blood ...

Historical Employee Count of ADMA

Current

647

Change

-5.55%

Minimum

527

Maximum

685

Recent Filings

Report Date	Employees	Form Type	Filing Date	SEC Filing
Dec 31, 2025	647	10-K	Feb 25, 2026	View
Dec 31, 2024	685	10-K	Mar 18, 2025	View
Dec 31, 2023	624	10-K	Feb 28, 2024	View
Dec 31, 2022	617	10-K	Mar 23, 2023	View
Dec 31, 2021	527	10-K	Mar 24, 2022	View

Supply Chain of ADMA

Upstream / Downstream / Proxies

Upstream

Third-Party High-Titer Plasma Suppliers (Multiple Contracted Partners)ADMA BioCenters (Wholly-Owned Subsidiary)Biotest AG / Biotest Pharmaceuticals CorporationHaemonetics CorporationNYSE:HAEBioCare, Inc. (BioCareSD)

Downstream

BioCare, Inc. (BioCareSD)McKesson Corporation (McKesson Specialty)NYSE:MCK Cencora, Inc. (formerly AmerisourceBergen)NYSE:COR Cardinal Health, Inc.NYSE:CAHFFF Enterprises, Inc.Reliance Life Sciences Pvt. LimitedTakeda Pharmaceutical Company Limited (BioLife Plasma Services)NYSE:TAK

Proxies

CSL Limited (CSL Behring)ASX:CSLGrifols, S.A.NASDAQ:GRFS Takeda Pharmaceutical Company LimitedNYSE:TAK

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer